---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-25-005489"
form_type: "8-K"
ticker: "ADMA"
cik: "0001368514"
company_name: "ADMA BIOLOGICS, INC."
filed_at: "2025-02-21T23:59:59+00:00"
generated_at: "2026-05-26T06:52:49.054903+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# ADMA Biologics sets 2025 executive comp; CEO Grossman base $925k with equity awards

## Summary
- CEO Grossman: 2025 base $925k, 2024 cash bonus $1.02M, 252,022 RSUs, 376,744 options at $16.07 strike.
- COO Kestenberg: 2025 base $575k, 2024 bonus $293,625, 77,784 RSUs, 116,279 options.
- CFO Tade: 2025 base $500k, 2024 bonus $254,475, 62,227 RSUs, 93,023 options.
- Non-employee directors get annual equity grants of $350k (50% RSUs, 50% options) and increased committee retainers.

## SEC filing metadata
- accession: 0001140361-25-005489
- form_type: 8-K
- ticker: ADMA
- cik: 0001368514
- company_name: ADMA BIOLOGICS, INC.
- filed_at: 2025-02-21T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1368514/000114036125005489/0001140361-25-005489-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1368514/000114036125005489/ef20044064_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-25-005489
- JSON: https://secwatch.observer/filing/0001140361-25-005489.json
- Plain text: https://secwatch.observer/filing/0001140361-25-005489.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.